SPP1 and kidney disorder: The step-forward approach selected a biomarker panel of sCr, osteopontin, tryptase, urea, and eGFR and had an accuracy of 84.3% and 83.3%, including the basic covariates age, body mass index, follow-up time, kidney disease diagnosis, and gender.